Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tilmann Bochtler

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|June 6, 2019
Does Cancer of Unknown Primary (CUP) Truly Exist as a Distinct Cancer Entity?Tilmann Bochtler, Alwin Krämer
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
EnasidenibAlwin Krämer, Tilmann Bochtler
Seminars in Diagnostic Pathology|December 6, 2017
Diagnosis and management of metastatic neoplasms with unknown primaryTilmann Bochtler, Harald Löffler, Alwin Krämer
Radiologie (Heidelberg, Germany)|March 17, 2023
[Cancer of unknown primary-The new ESMO guidelines]Tilmann Bochtler, Maria Pouyiourou, Alwin Krämer
Radiologie (Heidelberg, Germany)|March 22, 2023
[Cancer of unknown primary (CUP)-single-site, oligometastatic, and in the head and neck region]Maria Pouyiourou, Sebastian Regnery, Tilmann Bochtler, et al.
Leukemia|August 25, 2019
TP53 deficiency permits chromosome abnormalities and karyotype heterogeneity in acute myeloid leukemiaAnna Cazzola, Christin Schlegel, Ilka Jansen, et al.
Leukemia|December 19, 2025
Etiology of TP53 mutated complex karyotype acute myeloid leukemiaAnna Fedenko, Honorata Czapinska, Alwin Krämer, et al.
Deutsches Arzteblatt International|February 7, 2019
Hematological Malignancies in Adults With a Family PredispositionTilmann Bochtler, Georg-Martin Haag, Sarah Schott, et al.
Nature Reviews. Clinical Oncology|August 4, 2025
Rethinking cancer of unknown primary: from diagnostic challenge to targeted treatmentMaria Pouyiourou, Tilmann Bochtler, Chantal Pauli, et al.
European Journal of Haematology|March 18, 2014
Azacitidine and low-dose cytarabine in palliative patients with acute myeloid leukemia and high bone marrow blast counts--a retrospective single-center experienceAleksandar Radujkovic, Sascha Dietrich, Tilmann Bochtler, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|June 6, 2019
Does Cancer of Unknown Primary (CUP) Truly Exist as a Distinct Cancer Entity?Tilmann Bochtler, Alwin Krämer
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
EnasidenibAlwin Krämer, Tilmann Bochtler
Seminars in Diagnostic Pathology|December 6, 2017
Diagnosis and management of metastatic neoplasms with unknown primaryTilmann Bochtler, Harald Löffler, Alwin Krämer
Radiologie (Heidelberg, Germany)|March 17, 2023
[Cancer of unknown primary-The new ESMO guidelines]Tilmann Bochtler, Maria Pouyiourou, Alwin Krämer
Radiologie (Heidelberg, Germany)|March 22, 2023
[Cancer of unknown primary (CUP)-single-site, oligometastatic, and in the head and neck region]Maria Pouyiourou, Sebastian Regnery, Tilmann Bochtler, et al.
Leukemia|August 25, 2019
TP53 deficiency permits chromosome abnormalities and karyotype heterogeneity in acute myeloid leukemiaAnna Cazzola, Christin Schlegel, Ilka Jansen, et al.
Leukemia|December 19, 2025
Etiology of TP53 mutated complex karyotype acute myeloid leukemiaAnna Fedenko, Honorata Czapinska, Alwin Krämer, et al.
Deutsches Arzteblatt International|February 7, 2019
Hematological Malignancies in Adults With a Family PredispositionTilmann Bochtler, Georg-Martin Haag, Sarah Schott, et al.
Nature Reviews. Clinical Oncology|August 4, 2025
Rethinking cancer of unknown primary: from diagnostic challenge to targeted treatmentMaria Pouyiourou, Tilmann Bochtler, Chantal Pauli, et al.
European Journal of Haematology|March 18, 2014
Azacitidine and low-dose cytarabine in palliative patients with acute myeloid leukemia and high bone marrow blast counts--a retrospective single-center experienceAleksandar Radujkovic, Sascha Dietrich, Tilmann Bochtler, et al.
Pageof 6